Compagnie Lombard Odier SCmA’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.59M | Hold |
|
|||||
|
2025
Q1 | $6.09M | Buy |
|
|||||
|
2024
Q4 | $3.85M | Sell |
|
|||||
|
2024
Q3 | $4.85M | Buy |
|
|||||
|
2024
Q2 | $3.39M | Buy |
|
|||||
|
2024
Q1 | $1.8M | Buy |
|
|||||
|
2023
Q4 | $529K | Hold |
|
|||||
|
2023
Q3 | $452K | Sell |
|
|||||
|
2023
Q2 | $669K | Hold |
|
|||||
|
2023
Q1 | $599K | Sell |
|
|||||
|
2022
Q4 | $1.59M | Buy |
|
|||||
|
2022
Q3 | $376K | Sell |
|
|||||
|
2022
Q2 | $460K | Hold |
|
|||||
|
2022
Q1 | $425K | Hold |
|
|||||
|
2021
Q4 | $358K | Buy |
|
|||||
|
2021
Q3 | $69K | Hold |
|
|||||
|
2021
Q2 | $76K | Buy |
|
|||||
|
2021
Q1 | $54K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $94K | Buy |
|
|||||
|
2020
Q1 | $59K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $50K | Sell |
|
|||||
|
2018
Q3 | $96K | Hold |
|
|||||
|
2018
Q2 | $85K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $63K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $204K | Sell |
|
|||||
|
2014
Q2 | $586K | Buy |
|
|||||
|
2014
Q1 | $261K | Buy |
|
|||||
|
2013
Q4 | $173K | Buy |
|